biomea fusion
Anu Garg has over twenty years of experience in analytical chemistry development and quality control. They have held various executive and directorial positions in companies such as Biomea Fusion, Rain Oncology, Portola Pharmaceuticals, Onyx Pharmaceuticals, ALEXZA Pharmaceuticals, ALZA Corporation, and Cygnus, Inc. Their roles have involved managing analytical activities for drug substance and drug product manufacturing, overseeing method development and transfer, and writing CMC analytical sections for regulatory submissions. They have also conducted stability studies and collaborated with contract research organizations.
Anu Garg holds a M.S. in Chemistry from the University of Guelph and a Ph.D. in Chemistry from CCS (Chaudhary Charan Singh) University.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.